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The present study. In this issue of the Journal, Chang et 
al. 0) report on the results of cardiac catheterization in 
patients with hypoplastic left heart syndrome who had 
previously undergone a palliative Norwood operation and 
were being considered for a modified Fontan procedure. 
This excellent study attempts to delineate preoperative 
factors that may establish differences between survivors and 
non survivors of the latter procedure. 
The report is based on the extensive experience accumu-
lated by the authors 0) with the initial palliative treatment of 
these infants. It focuses on the cohort of patients who 
survived the initial operation and underwent elective cardiac 
catheterization in preparation for definitive surgical repair. 
Fifty-nine patients met this inclusion criterion. 
Problems involved in selecting patients for the Norwood 
operation. The difficulties experienced in attempting to pro-
vide palliative treatment for this group of infants include 
those that continue to result in a high initial operative 
mortality rate. Additionally, major problems are encoun-
tered in preserving the morphologic and hemodynamic vari-
ables necessary for inclusion in the selection criteria for the 
Fontan operation. Given the nature of the anomaly and the 
technical aspects of the Norwood procedure, the following 
variables are of significance at the time of elective cardiac 
catheterization: 1) architecture of the pulmonary artery 
confluence and its branches; 2) the systolic and diastolic 
properties of the single functional ventricular chamber; 3) 
the function of the single atrioventricular (AV) valve; 4) the 
status of the pulmonary arterioles; and 5) the condition of the 
atrial septum. Indeed, survivors of the Norwood operation 
face potential problems in all areas. The extensive recon-
struction of the pulmonary artery confluence necessary 
during the initial palliative operation may result in significant 
distortion or scarring of the pulmonary arteries, or both. The 
systolic and diastolic properties of the morphologic right 
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ventricle can be affected adversely by its architecture, by the 
volume overload resulting from the common mixing and the 
systemic to pulmonary shunt and by the pressure overload 
that may result from residual obstruction to aortic runoff. 
Atrioventricular valve dysfunction, particularly insuffi-
ciency, may further complicate the overall hemodynamic 
situation. 
Selection of patients: effect on mortality. In their report, 
the authors 0) describe a total group of 135 hospital survi-
vors of the Norwood procedure. Yet their data include only 
59 of those patients, all of whom underwent a modified 
Fontan procedure or a superior cavopulmonary anastomo-
sis. We must then assume that the other hospital survivors of 
initial palliation are not included in this group for several 
reasons: 1) late mortality, 2) recent palliation (young age), 
and 3) inadequate anatomic or hemodynamic characteristics 
for the Fontan procedure as assessed by a method other than 
cardiac catheterization (echocardiography). A significant 
number of patients included in their report had undergone 
interim surgical procedures necessary to correct problems 
remaining after initial palliation. These included relief of 
persistent aortic obstruction or shunt revision or atrial 
septectomy, or both of the latter two procedures. No patient 
underwent interim reconstruction of pulmonary artery prob-
lems or repair of A V valve insufficiency. 
Analysis of the authors' Table 2 is sobering. For patients 
without risk factors, the overall mortality rate was 30%. For 
patients with significant risk factors excluding pulmonary 
artery distortion, the overall mortality rate was >50%. 
Indeed, the high risk of the modified Fontan operation in the 
patients with "no risk factors" may be simply explained by 
their young age, a recognized risk factor for the Fontan 
procedure in general (2). 
Proposed modifications in management protocol. Im-
provement in these results, as suggested by the authors, may 
require significant modifications in their management proto-
col. 
1. Delay of the modified Fontan procedure until a more 
favorable age is attained. If interim palliation is necessary 
because of increasing cyanosis, the superior cavopulmonary 
anastomosis appears to be the best alternative. It increases 
pulmonary artery blood flow and reduces the volume load on 
the ventricle. 
2. Modification of correctable risk factors before the 
Fontan operation. Interim surgical correction of AV valve 
insufficiency through valve replacement or annuloplasty is 
sometimes necessary in an effort to allow optimal recovery 
of ventricular function before the Fontan operation. The 
same principle applies to surgical correction of pulmonary 
artery distortion not amenable to relief through a median 
sternotomy approach at the time of the Fontan procedure. If 
pulmonary artery resistance is elevated because of persistent 
restriction at the level of the atrial septum, time may be 
required after atrial septectomy for involution of the pulmo-
nary arteriolar vasculature. 
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3. Refinement of criteria selection for the modified F on-
tan procedure. Absolute contraindications to the Fontan 
operation include elevation of pulmonary arteriolar resis-
tance and hypoplasia of the pulmonary arteries. Relative 
contraindications include young age, pulmonary artery dis-
tortion, A V valve insufficiency and "poor" ventricular func-
tion (2,3). In selecting patients for the Fontan procedure 
versus cavopulmonary anastomosis, these considerations 
must be taken into account. 
Role of cardiac transplantation. The continuous attrition 
of these patients at all levels of their palliative surgery 
continues to be a worrisome feature of this surgical ap-
proach. Until further improvement in the results with this 
staged management protocol can be obtained, other alterna-
tives must be explored. 
1. Transplantation in the newborn period continues to be 
a viable alternative. The limiting factor is the availability of 
suitable donors and the time constraint imposed by the 
natural history of hypoplastic left heart syndromes. 
2. Consideration of the Norwood operation as a bridge 
to transplantation, not as a bridge to the Fontan procedure, 




survived the Norwood operation and who do not fit the rigid 
inclusion criteria for the Fontan procedure must be consid-
ered for transplantation (4,5). 
The authors of this report deserve praise and encourage-
ment for their pioneering work on behalf of this difficult 
group of patients. 
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